- Home
- CADL vs IMMR Comparison
CADL vs IMMR Comparison
Compare CADL & IMMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- IMMR
- Stock Information
- Founded
- CADL 1999
- IMMR 1993
- Country
- CADL United States
- IMMR United States
- Employees
- CADL N/A
- IMMR N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- IMMR Computer peripheral equipment
- Sector
- CADL Health Care
- IMMR Technology
- Exchange
- CADL Nasdaq
- IMMR Nasdaq
- Market Cap
- CADL 250.0M
- IMMR 251.7M
- IPO Year
- CADL 2021
- IMMR 1999
- Fundamental
- Price
- CADL $6.57
- IMMR $7.07
- Analyst Decision
- CADL Strong Buy
- IMMR Strong Buy
- Analyst Count
- CADL 5
- IMMR 2
- Target Price
- CADL $21.40
- IMMR $12.25
- AVG Volume (30 Days)
- CADL 1.0M
- IMMR 450.6K
- Earning Date
- CADL 08-12-2025
- IMMR 08-19-2025
- Dividend Yield
- CADL N/A
- IMMR 2.56%
- EPS Growth
- CADL N/A
- IMMR 57.07
- EPS
- CADL N/A
- IMMR 2.04
- Revenue
- CADL N/A
- IMMR $163,133,000.00
- Revenue This Year
- CADL N/A
- IMMR $988.71
- Revenue Next Year
- CADL N/A
- IMMR $109.72
- P/E Ratio
- CADL N/A
- IMMR $3.45
- Revenue Growth
- CADL N/A
- IMMR 338.21
- 52 Week Low
- CADL $3.79
- IMMR $6.47
- 52 Week High
- CADL $14.60
- IMMR $13.00
- Technical
- Relative Strength Index (RSI)
- CADL 57.39
- IMMR 33.80
- Support Level
- CADL $6.35
- IMMR $7.01
- Resistance Level
- CADL $7.21
- IMMR $7.66
- Average True Range (ATR)
- CADL 0.43
- IMMR 0.23
- MACD
- CADL -0.00
- IMMR -0.07
- Stochastic Oscillator
- CADL 53.74
- IMMR 6.06
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About IMMR Immersion Corporation
Immersion Corp is focused on the creation, design, development, and licensing of haptic technologies that allow people to use its sense of touch more fully as it involves engaging with products and experience the digital world. The company's software focuses on applications in mobile devices, wearables, consumer, and gaming devices markets. It generates revenue from royalty and license fees, and development contract and service fees. Geographically, the company generates a majority of its revenue from Japan, followed by Korea, Germany, United States of America and other countries.